Myelodysplastic Syndrome
Showing NaN - NaN of 18
Chronic Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia-1, Chronic Myelomonocytic Leukemia-2 Trial in Canada, United
Active, not recruiting
- Chronic Myelomonocytic Leukemia
- +6 more
- Azacitidine
- +3 more
-
Birmingham, Alabama
- +297 more
Jan 28, 2023
Acute Myeloid Leukemia, Down Syndrome, Myelodysplastic Syndrome Trial in Worldwide (Asparaginase, Asparaginase Erwinia
Active, not recruiting
- Acute Myeloid Leukemia
- +4 more
- Asparaginase
- +7 more
-
Birmingham, Alabama
- +190 more
Jan 30, 2023
Acute Myeloid Leukemia, Myelodysplastic Syndrome, Myelodysplastic Syndrome With Excess Blasts-2 Trial in United States (drug,
Active, not recruiting
- Acute Myeloid Leukemia
- +2 more
- Azacitidine
- +5 more
-
Anchorage, Alaska
- +506 more
Jan 28, 2023
Collection of Tissue Samples for Cancer Research
Recruiting
- Neoplasms
- +3 more
- Biopsy
-
Atlanta, Georgia
- +9 more
Jan 23, 2023
Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States
Completed
- Acute Myeloid Leukemia
- +19 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Lewes, Delaware
- +16 more
Aug 3, 2022
Anemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome Trial in United States (biological, other, drug)
Active, not recruiting
- Anemia
- +3 more
- Epoetin Alfa
- +2 more
-
Birmingham, Alabama
- +512 more
Mar 1, 2022
Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia Trial in Atlanta, Saint Louis, Columbus
Active, not recruiting
- Acute Myelogenous Leukemia
- +10 more
- BL-8040
- +2 more
-
Atlanta, Georgia
- +2 more
Feb 9, 2022
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
Active, not recruiting
- Acute Leukemia
- +3 more
- cytogenetic analysis
-
La Jolla, California
- +136 more
Aug 16, 2021
Myelodysplastic Syndrome, Iron Overload Trial in Canada, United States (Deferasirox)
Completed
- Myelodysplastic Syndrome
- Iron Overload
-
Birmingham, Alabama
- +47 more
Jul 21, 2021
Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in France, United States (oral
Completed
- Myelodysplastic Syndrome
- +2 more
- oral rigosertib
- Azacitidine
-
Gilbert, Arizona
- +12 more
Jun 15, 2021
Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia Trial in Saint Louis (drug, radiation, procedure)
Terminated
- Acute Myeloid Leukemia
- +2 more
- Fludarabine
- +8 more
-
Saint Louis, MissouriWashington University School of Medicine
Oct 16, 2020
Related Donors Donating PBSC to a Family Member, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in United States
Completed
- Related Donors Donating PBSC to a Family Member
- +7 more
-
Tampa, Florida
- +11 more
Sep 3, 2020
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in United States (Preparative Regimen, NK Cells, Interleukin-2)
Completed
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Preparative Regimen
- +4 more
-
Atlanta, Georgia
- +3 more
Apr 29, 2020
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Canada, United States (Co-ArgI-PEG modified human arginase I)
Completed
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Co-ArgI-PEG modified human arginase I
-
Ann Arbor, Michigan
- +9 more
Oct 15, 2018
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome
Completed
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
- +5 more
- Ipilimumab
- Laboratory Biomarker Analysis
-
New Haven, Connecticut
- +8 more
Mar 20, 2018
Myelodysplastic Syndrome Trial in Worldwide (eltrombopag olamine, Placebo)
Completed
- Myelodysplastic Syndrome
- eltrombopag olamine
- Placebo
-
Birmingham, Alabama
- +64 more
Nov 8, 2017